Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN.

Autor: Guilhem-Ducléon G; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France., Dalban C; Department of Clinical Research and Innovation, Centre de Lutte Contre Le Cancer, Centre Léon Bérard, Lyon, France., Negrier S; University Lyon I, Centre Léon Bérard, Lyon, France., Gravis G; Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France., Laguerre B; Department of Medical Oncology, Centre Eugene Marquis, Rennes, France., Chevreau C; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Oudard S; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP-Centre, Université Paris Cité, Paris, France., Barthelemy P; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Ladoire S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Boughalem E; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, 49055 Angers, France., Borchiellini D; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Linassier C; Department of Medical Oncology, CHU Bretonneau et Université de Tours, Tours, France., Nenan S; Unicancer, Paris, France., Flippot R; Department of Medical Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Albiges L; Department of Medical Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Goupil MG; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France. Electronic address: marine.gross-goupil@chu-bordeaux.fr.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Dec; Vol. 21 (6), pp. 643-652. Date of Electronic Publication: 2023 Jul 20.

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).

Autor: Gillessen S; EOC-Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Procopio G; Fondazione Istituto Nazionale dei Tumori, Milano, Italy., Hayoz S; Competence Center of SAKK, Bern, Switzerland., Kremer E; Competence Center of SAKK, Bern, Switzerland., Schwitter M; Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland., Caffo O; Presidio Ospedaliero Santa Chiara, Trento, Italy., Lorente D; Consorci Hospitalari Provincial de Castellón, Castellón de la Plana, Spain., Pedrazzini A; Fondazione Oncologia Lago Maggiore, Locarno, Switzerland., Roubaud G; Institut Bergonié, Bordeaux, France., Nenan S; Unicancer, Département de la recherche et développement, Groupe d'étude des tumeurs urogénitales (GETUG), Paris, France., Omlin A; Department of Hematology and Oncology, Kantonsspital St Gallen, St Gallen, Switzerland.; Onkozentrum Zürich Seefeld, Zürich, Switzerland., Buttigliero C; Department of Oncology, University of Torino, S. Luigi Hospital, Orbassano (Torino), Italy., Delgado Mingorance JI; Hospital Infanta Cristina, Badajoz, Spain., González-Del-Alba A; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Delgado MT; Hospital Universitario San Cecilio, Granada, Spain., Nole F; Istituto Europeo di Oncologia (IEO), Milano, Italy., Turco F; EOC-Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.; Department of Oncology, University of Torino, S. Luigi Hospital, Orbassano (Torino), Italy., Pereira Mestre R; EOC-Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland., Ribi K; Competence Center of SAKK, Bern, Switzerland.; IBCSG Coordinating Office, Bern, Switzerland., Cathomas R; Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jul 10; Vol. 41 (20), pp. 3608-3615. Date of Electronic Publication: 2023 Feb 08.

1680P Feasibility of home-based supervised physical activity (SPA) for metastatic cancer patients receiving oral targeted therapy: The AFSOS-Unicancer QUALIOR randomized phase II study

Autor: Lobbedez, F. Joly, Lefeuvre-Plesse, C., Charton, E., Helissey, C., Priou, F., Stefani, L., Simmet, V., Garnier-Tixidre, C., Meneveau, N., Houede, N., Salas, S., Bourbouloux, E., Descotes, J-M., Anota, A., Nenan, S., Rieger, I.

Publikováno v: In Annals of Oncology September 2021 32 Supplement 5:S1178-S1178

What Is on the Horizon for Treatments in Idiopathic Pulmonary Fibrosis?

Autor: Moua, Teng¹ (AUTHOR) baqir.misbah@mayo.edu, Baqir, Misbah¹ (AUTHOR), Ryu, Jay H.¹ (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6304. 19p.

Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial.

Autor: Dumont C; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Baciarello G; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Bosset PO; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Lavaud P; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Colomba E; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Massard C; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Loriot Y; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Albiges L; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Blanchard P; Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France., Bossi A; Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France., Nenan S; Genitourinary Cancer Study Group (GETUG), Unicancer, Kremin-Bicêtre, France., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France. Electronic address: karim.fizazi@gustaveroussy.fr.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Dec; Vol. 18 (6), pp. 444-451. Date of Electronic Publication: 2020 Apr 07.